These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14994381)

  • 1. Hepatitis C and B cells: induction of autoimmunity and lymphoproliferation may reflect chronic stimulation through cell-surface receptors.
    Starkebaum G; Sasso EH
    J Rheumatol; 2004 Mar; 31(3):416-8. PubMed ID: 14994381
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cells and mixed cryoglobulinemia.
    Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
    Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings.
    Ferraccioli G; Tolusso B
    Autoimmun Rev; 2007 Dec; 7(2):109-13. PubMed ID: 18035319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation.
    Zignego AL; Piluso A; Giannini C
    Autoimmun Rev; 2008 Dec; 8(2):107-11. PubMed ID: 18700171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV and lymphoproliferation.
    Zignego AL; Giannini C; Gragnani L
    Clin Dev Immunol; 2012; 2012():980942. PubMed ID: 22852020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells and herpesviruses: a model of lymphoproliferation.
    Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Forghieri F; Torelli G; Luppi M
    Autoimmun Rev; 2007 Dec; 7(2):132-6. PubMed ID: 18035323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
    Defrancesco I; Visentini M; Zibellini S; Minafò YA; Rattotti S; Ferretti VV; Rizzo E; Varettoni M; Frigeni M; Pulsoni A; Casato M; Colantuono S; Rossi M; Candido C; Zerbi C; Bergamini F; Cristinelli C; Fabbri N; Merli M; Zuccaro V; Bruno R; Paulli M; Arcaini L
    Am J Hematol; 2021 Jun; 96(6):E210-E214. PubMed ID: 33755245
    [No Abstract]   [Full Text] [Related]  

  • 11. Receptors for mouse erythrocytes on human immature B lymphocytes: still a valuable tool in immunohaematology.
    Youinou PY; Lydyard PM
    Diagn Clin Immunol; 1987; 5(2):112-4. PubMed ID: 3040291
    [No Abstract]   [Full Text] [Related]  

  • 12. B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies.
    Bhat NM; Bieber MM; Yang YC; Leu YS; van Vollenhoven RF; Teng NN
    Hum Antibodies; 2004; 13(3):63-8. PubMed ID: 15598986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV-associated lymphomas.
    Fiorilli M; Mecucci C; Farci P; Casato M
    Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and lymphoproliferation: two genes are worse than one.
    Cohen PL
    Mol Interv; 2002 Nov; 2(7):427-30. PubMed ID: 14993405
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
    Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C-related posttransplant plasma cell proliferative disorder with hepatitis C virus in neoplastic plasma cells: a new posttransplant disease entity?
    Tun HW; Krishna M; Menke DM
    Transplant Proc; 2004 Nov; 36(9):2692-6. PubMed ID: 15621126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites and stages of autoreactive B cell activation and regulation.
    Shlomchik MJ
    Immunity; 2008 Jan; 28(1):18-28. PubMed ID: 18199415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling in B cells via Toll-like receptors.
    Peng SL
    Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell tolerance checkpoints in health and autoimmunity.
    Meffre E; Wardemann H
    Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocytes on the front line of autoimmunity.
    Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
    Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.